Literature DB >> 14499942

Elevated neurofilament levels in neurological diseases.

Niklas Norgren1, Lars Rosengren, Torgny Stigbrand.   

Abstract

Neurofilaments, a major cytoskeletal constituent of neuronal cells, can be released into the cerebrospinal fluid during several neurodegenerative diseases. By means of a new sensitive ELISA capable of measuring 60 ng/l of neurofilament light, significant elevations were observed for different neurological disorders. Cerebral infarction presented levels of 19800+/-9100 ng/l, amyothropic lateral sclerosis 3600+/-1200 ng/l, 'relapsing-remitting' MS 2500+/-1500 ng/l, extrapyramidal symptoms 1100+/-300 ng/l, late onset AD 300+/-100 ng/l and vascular dementia 1400+/-800 ng/l. In patients with no signs of neurological diseases the upper normal level and cut-off values was determined to be below 100 ng/l. NF-L determinations will be a valuable complement in identifying neuronal degradation and can be used clinically for diagnostic and monitoring purposes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499942     DOI: 10.1016/s0006-8993(03)03219-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  103 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

2.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

3.  Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports.

Authors:  Pashtun Shahim; Henrik Zetterberg; Yelverton Tegner; Kaj Blennow
Journal:  Neurology       Date:  2017-04-12       Impact factor: 9.910

Review 4.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

5.  Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.

Authors:  Roberto Madeddu; Cristiano Farace; Paola Tolu; Giuliana Solinas; Yolande Asara; Maria Alessandra Sotgiu; Lucia Gemma Delogu; Jose Carlos Prados; Stefano Sotgiu; Andrea Montella
Journal:  Neurol Sci       Date:  2012-02-24       Impact factor: 3.307

Review 6.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

7.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

8.  Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus.

Authors:  Ronald J Ellis; Scott Peterson; Mariana Cherner; Erin Morgan; Rachel Schrier; Bin Tang; Martin Hoenigl; Scott Letendre; Jenny Iudicello
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

9.  CSF neurofilament protein analysis in the differential diagnosis of ALS.

Authors:  Thierry S Reijn; Wilson F Abdo; Helenius J Schelhaas; Marcel M Verbeek
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

Review 10.  ALS biomarkers for therapy development: State of the field and future directions.

Authors:  Michael Benatar; Kevin Boylan; Andreas Jeromin; Seward B Rutkove; James Berry; Nazem Atassi; Lucie Bruijn
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.